Published Date: 28-Feb-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Global Clinical Decision Support Systems Market, published by KBV research, The Global Clinical Decision Support Systems Market size is expected to reach $8.2 billion by 2027, rising at a market growth of 10.7% CAGR during the forecast period.
The Services market is generating high revenue in the Global Clinical Decision Support Systems Market by Component 2020, thereby, achieving a market value of $3.4 billion by 2027. The maintenance of components and their accessories is one of CDSS's services. It includes hardware and software upgrades, as well as access to a knowledge library that contains the most up-to-date advances and drugs.
The Integrated E.H.R. with CDSS market shows highest growth rate of 11% during (2021 - 2027). The growing use of EHR by multi-specialty health care units is expected to have an impact on the segment's growth. When CDS systems are coupled with EHR, CDSS receives the patient's database and history, allowing it to deliver clinical solutions and prescription recommendations to the practitioner, thereby automating the clinical workflow. CDSS and EHRs are frequently connected to improve workflows and make better use of existing data sets. The number of CDSS functions included in EHR systems is growing, hence supporting the growth of the segment.
The On-premise Systems market acquired maximum revenue share in the Global Clinical Decision Support Systems Market by Delivery Mode 2020, thereby, achieving a market value of $3.5 billion by 2027. The growth of this segment is due to the rapid adoption of the equipment. Moreover, multispecialty hospitals and large-scale healthcare organizations use this technology to secure their data. Data security and threat minimization are two additional benefits supplied to the user, making it the favored choice for end-users.
The Drug Allergy Alerts market segment shows high market share in the Global Clinical Decision Support Systems Market by Application 2020, thereby, achieving a market value of $2.5 billion by 2027. The increased growth of this segment is attributed to the fact that many people are allergic to certain pharmaceuticals, it is critical to have systems in place that send notifications related to allergy. A medical error can occur during the process of prescribing, dispensing or administering a prescription, and it can have serious consequences, such as giving medication to a patient who has a documented allergy to that substance. Hence, these factors would propel the growth of the clinical support systems market during the forecasting period.
The North America market is the fastest growing region in the Global Clinical Decision Support Systems Market by Region 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $3.4 billion by 2027. The Europe market is expected to witness a CAGR of 9.8% during (2021 - 2027). Additionally, The Asia Pacific market is expected to witness a CAGR of 12.8% during (2021 - 2027).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Siemens Healthineers AG (Siemens AG), Cerner Corporation (Oracle Corporation), AllScripts Healthcare Solutions, Inc., General Electric (GE) Co. (GE Healthcare), NextGen Healthcare, Inc., Athenahealth, Inc. (Veritas Capital), Epic Systems Corporation, eClinicalWorks LLC, Change Healthcare, Inc., and Zynx Health, Inc. (Hearst Communications, Inc.).
By Delivery Mode
Unique Offerings from KBV Research